Detalles de la búsqueda
1.
Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases.
Strahlenther Onkol
; 198(8): 683-689, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35704054
2.
Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinoma.
Radiat Environ Biophys
; 61(2): 255-262, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35084511
3.
German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy.
Urol Int
; 106(5): 431-439, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35144260
4.
Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO).
Strahlenther Onkol
; 197(11): 993-1000, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463814
5.
Radiotherapy in nodal oligorecurrent prostate cancer.
Strahlenther Onkol
; 197(7): 575-580, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914101
6.
Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer.
Strahlenther Onkol
; 197(2): 89-96, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33301049
7.
Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer : In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5.
Curr Oncol Rep
; 23(2): 18, 2021 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33471212
8.
Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer.
Strahlenther Onkol
; 196(7): 589-597, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32166452
9.
Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer : Statement from the DEGRO working group on prostate cancer.
Strahlenther Onkol
; 196(2): 109-116, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31784804
10.
Side effects of proton beam therapy of choroidal melanoma in dependence of the dose to the optic disc and the irradiated length of the optic nerve.
Graefes Arch Clin Exp Ophthalmol
; 258(11): 2523-2533, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32533280
11.
Impact of bladder volume on acute genitourinary toxicity in intensity modulated radiotherapy for localized and locally advanced prostate cancer.
Strahlenther Onkol
; 195(6): 517-525, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30443682
12.
The impact of prostate-specific antigen persistence after radical prostatectomy on the efficacy of salvage radiotherapy in patients with primary N0 prostate cancer.
BJU Int
; 124(5): 785-791, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31220400
13.
Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.
Strahlenther Onkol
; 194(7): 619-626, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29383406
14.
Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.
Acta Oncol
; 57(3): 362-367, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28816074
15.
Dosimetric implications of inter- and intrafractional prostate positioning errors during tomotherapy : Comparison of gold marker-based registrations with native MVCT.
Strahlenther Onkol
; 193(9): 700-706, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28466155
16.
Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy : Informing the debate.
Strahlenther Onkol
; 193(9): 692-699, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28470414
17.
Hypofractionated radiotherapy for localized prostate cancer.
Strahlenther Onkol
; 193(1): 1-12, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27628966
18.
Cataract development in patients treated with proton beam therapy for uveal melanoma.
Graefes Arch Clin Exp Ophthalmol
; 254(8): 1625-1630, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27116211
19.
Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutation.
Eur J Haematol
; 95(1): 90-2, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24935205
20.
[Primary radiotherapy and short androgen deprivation therapy of 18 months may be sufficient in patients with localized prostate cancer with high-risk-factor compared to the standard of 28 to 36 months.] / Eine definitive Strahlentherapie mit einer Kurzzeit Androgendeprivationstherapie von 18 Monaten kann bei Patienten mit lokal begrenztem Prostatakarzinom mit hohen Risikofaktoren gegenüber dem Standard von 2836 Monaten ausreichend sein.
Strahlenther Onkol
; 195(8): 764-766, 2019 08.
Artículo
en Alemán
| MEDLINE | ID: mdl-31073701